Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01467622
Other study ID # KSH-TCH-IIT-2009-1
Secondary ID
Status Completed
Phase N/A
First received October 30, 2011
Last updated May 6, 2013
Start date April 2009
Est. completion date October 2011

Study information

Verified date May 2013
Source Schillerhoehe Hospital
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Observational

Clinical Trial Summary

The effect of local chest-tube management protocols on the duration of chest-tube therapy following thoracic surgery was analyzed in four German specialized Thoracic Surgery Units. The primary study objective was the duration of chest tube therapy in postoperative patients.


Description:

The management of chest tubes is probably one of the most critical aspects in patient care in thoracic surgery and defines the required length of postoperative hospital stay in the majority of patients. So far, no generally accepted recommendations exist for postoperative chest tube management to streamline the postoperative stay. Instead, decision making in most thoracic surgery units is based on team preferences and individual training rather than scientific data. Therefore, digital pleural drainage systems represent a useful tool to standardize existing intradepartmental protocols for chest tube management. However, for the development of generally accepted protocol-recommendations, the diverging interdepartmental treatment protocols have to be analyzed and compared for superiority. In this IIT, the effect of different chest tube management protocols on chest tube duration is analyzed in four German Thoracic Surgery units.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date October 2011
Est. primary completion date August 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- age 18-85

- following pulmonary wedge resection, anatomic segmentectomy, or lobectomy

Exclusion Criteria:

- surgery for spontaneous pneumothorax (primary and secondary)

- surgery for pleural empyema

- present medication with corticoids, immunosuppressive drugs or platelet aggregation inhibitors other than Aspirin

- history of chemotherapy, radiotherapy of the chest, or previous ipsilateral thoracic surgery

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
Chest tube removal
Chest tube removal on the basis of local recommendations for postoperative chest tube management

Locations

Country Name City State
Germany Evangelische Lungenklinik Berlin Berlin
Germany Klinikum Bremen-Ost gGmbH Bremen
Germany Klinik Schillerhoehe Gerlingen
Germany Katholisches Klinikum Koblenz Koblenz

Sponsors (2)

Lead Sponsor Collaborator
Schillerhoehe Hospital Medela AG

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Linder A, Ertner C, Steger V, Messerschmidt A, Merk J, Cregan I, Timm J, Walles T. Postoperative chest tube management: snapshot of German diversity. Interact Cardiovasc Thorac Surg. 2012 Oct;15(4):622-6. Epub 2012 Jun 29. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary chest tube therapy duration number of days following thoracic surgery until chest tube was removed participants are followed for the duration of hospital stay, an expected average of 5 days No
Secondary presence of pulmonary air leak number of days the Medela Thopaz device detected a pulmonary air leak following thoracic surgery participants are followed for the duration of hospital stay, an expected average of 4 days No
See also
  Status Clinical Trial Phase
Completed NCT04068545 - Experiences With New Digital Surgical Drainage System in Thoracic Surgery
Completed NCT01775657 - Digital Versus Analog Pleural Drainage Following Pulmonary Resection N/A
Completed NCT01566032 - Digital Versus Analog Pleural Drainage in Patients With Pulmonary Air Leak N/A